Protalix BioTherapeutics Market Cap

Protalix BioTherapeutics has a market cap or net worth of €119.59 million as of December 5, 2025. Its market cap has increased by 5.51% in one year.

Market Cap

119.59M

Enterprise Value

101.38M

Revenue

52.71M

Ranking

n/a

PE Ratio

26.01

Stock Price

€1.48

Market Cap Chart

Since January 3, 2007, Protalix BioTherapeutics's market cap has increased from 6.34M to 119.59M, an increase of 1,785.34%. That is a compound annual growth rate of 16.78%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	119.59M	-10.56%
Dec 31, 2024	133.71M	13.82%
Dec 29, 2023	117.48M	80.88%
Dec 30, 2022	64.95M	94.95%
Dec 31, 2021	33.32M	-65.61%
Dec 31, 2020	96.87M	123.36%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	242.06B
Siemens Aktiengesellschaft	175.97B
Allianz SE	141.37B
Deutsche Telekom AG	131.00B
Siemens Energy AG	97.17B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	68.46B
Rheinmetall AG	68.36B
Deutsche Bank Aktiengesellschaft	59.35B

Market Cap Rankings